February 1, 2022
1 min read

US FDA okays Moderna’s Covid-19 jab for adults

Spikevax meets the FDA’s rigorous standards for safety, effectiveness and manufacturing quality required for approval…reports Asian Lite News

Moderna’s Covid-19 vaccine has received full approval from the US Food and Drug Administration (FDA).

The vaccine, named Spikevax, is approved for use in people ages 18 and older, Xinhua news agency reported.

Spikevax meets the FDA’s rigorous standards for safety, effectiveness and manufacturing quality required for approval, said the agency in a statement.

“While millions of people have already safely received Covid-19 vaccines, we recognize that for some, the FDA approval of a vaccine may now instill additional confidence to get vaccinated,” said Acting FDA Commissioner Janet Woodcock.

“Today’s milestone puts us one step closer to altering the course of this pandemic in the US,” she said.

Moderna’s Covid-19 vaccine is the second one in the US to receive full approval from the FDA. Pfizer’s Covid-19 vaccine, Comirnaty, was fully approved for use in people ages 16 and older in August 2021.



Moderna’s Covid-19 vaccine has been available under the FDA’s emergency use authorization for individuals 18 years of age and older since December 18, 2020.

Moderna had earlier began clinical trials of a booster dose of a vaccine designed specifically to combat the Omicron variant of COVID-19.

CNN reported that the trials will involve a total of 600 adults, which will take place at up to 24 sites in the US. Some participants will have already received two doses of Moderna’s vaccine, and some will have received a booster shot.

“We are reassured by the antibody persistence against Omicron at six months after the currently authorized 50 mg booster of mRNA-1273. Nonetheless, given the long-term threat demonstrated by Omicron’s immune escape, we are advancing our Omicron-specific variant vaccine booster candidate and we are pleased to begin this part of our Phase 2 study,” CNN citing CEO Stephane Bancel’s statement reported.

“We are also evaluating whether to include this Omicron-specific candidate in our multivalent booster program,” it added.

ALSO READ: US Pentagon chief, Amir of Qatar hold talks on Afghanistan

Previous Story

Third-wave fear on ‘CLOTH MASK’

Next Story

US to impose sanctions on Putin’s aides

Latest from -Top News

Bangladesh Poll Prep: EC in Talks

Chief Election Commissioner said that the Election Commission is facing significant challenges working in the current situation in the country….reports Asian Lite News Ahead of the next general election in Bangladesh, planned

India Shows Sport Can Defeat Terror

India’s response to militancy blends military strength with a “softer” statecraft: sport….reports Asian Lite News The 60th session of the United Nations Human Rights Council in Geneva (8 September–8 October 2025) cast

Terror and Repression: Bangladesh Exposed in Geneva

Diplomats warn Bangladesh under Yunus risks instability, extremism, and civil conflict….reports Asian Lite News The Geneva-based rights group International Forum for Secular Bangladesh (IFSB) held a powerful poster exhibition in Geneva, drawing
Go toTop

Don't Miss

Israeli Prez set to address US Congress

Herzog’s visit will culminate in an address to a joint

Georgia appeals court pauses Trump’s election meddling case

Oral arguments are tentatively scheduled for October, which means that